Other grades of this product :
| Gatifloxacin hydrochloride Basic information |
| Product Name: | Gatifloxacin hydrochloride | | Synonyms: | Gatifloxacin base;4-dihydroquinoline-3-carboxylic acid;GatifloxacineHCL;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylicac;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-piperazin-1-yl)- 4-oxo-1,4-dihydro-quinoline-3-carboxylic acid hydrochloride;gatifloxacin hydrochloride;GATIFLOXACIN LACTATE;Gatifloxacin acid ester | | CAS: | 160738-57-8 | | MF: | C22H28FN3O7 | | MW: | 465.47 | | EINECS: | 1308068-626-2 | | Product Categories: | API | | Mol File: | 160738-57-8.mol |
| Gatifloxacin hydrochloride Chemical Properties |
| Gatifloxacin hydrochloride Usage And Synthesis |
| Description | Gatifloxacin is a novel orally-active fluoroquinolone antibiotic with a
potent and broad spectrum of activity against gram-positive (S.pneumonia,
S.aureus) and gram-negative bacteria. It shows good activity against strains
resistant to established antituberculosis agents. Gatifloxacin was marketed for the treatment of respiratory tract and urinary infections, particularly the treatment
of certain community-acquired infections (such as bronchitis, pneumonia and
common sexually-transmitted diseases). Comparative studies with ciprofloxacin,
ofloxacin and sparfloxacin against fluoroquinolone-resistant organisms indicated
a better or equivalent effectiveness with less phototoxic adverse effects. | | Chemical Properties | pale yellow prisms | | Originator | Kyori (Japan) | | Brand name | Tequin |
| Gatifloxacin hydrochloride Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye